Please join us at the Biotech Showcase 2019 Conference being held at the Hilton San Francisco. Our CEO Dr. Sandra Dunn will be presenting the latest exciting updates on our progress towards clinical trials for PMD-026, our promising treatment for Triple Negative Breast Cancer.